Teleflex Interventional Urology / The UroLift System
Treatment of Benign Prostatic Hyperplasia
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. The Interventional Urology Business Unit of Teleflex is dedicated to developing innovative, minimally invasive, and clinically effective devices that address unmet needs in the field of urology. Our focus is on improving the standard of care for patients with BPH using the UroLift® System, a proven, minimally invasive procedure that is the only leading BPH procedure shown to not cause new and lasting sexual dysfunction.*1-3 The UroLift System can be used to treat a broad spectrum of anatomies, including obstructive median lobe and prostates up to 100cc.4,5
*No instances of new, sustained erectile or ejaculatory dysfunction in the L.I.F.T. pivotal study
1. Roehrborn, Can J Urol 2017
2. AUA BPH Guidelines 2003, 2020
3. McVary, J Sex Med 2016
4. Rukstalis, Prostate Cancer and Prostatic Dis 2018
5. UroLift System Instructions for Use
MAC01921-01 Rev A
